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Abstract
Leptin is an adipose-derived hormone that regulates energy balance. Leptin receptors are expressed in extrahypothalamic sites and several reports showed that leptin 
can influence feeding and locomotor behavior via direct actions on dopaminergic neurons. The leptin deficient mouse (ob/ob) has been used as an animal model of 
blunted leptin action, and presents with obesity and mild type 2 diabetes. We used ob/ob mice to study the effect of repeated 7-day methamphetamine (METH) 
administration analyzing locomotion, behavioral sensitization, and somatosensory thalamic mRNA expression of voltage-gated calcium channels and glutamatergic 
receptors using RT-PCR. We observed reduced METH-mediated responses in ob/ob mice associated with enhanced in mRNA expression of key voltage-gated and 
glutamate receptors in the somatosensory thalamus. Results described here are important for understanding the control of locomotion and thalamocortical excitability 
by leptin. 
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Introduction
Leptin is an adipose-derived hormone [1] known to control 
appetite and energy expenditure [2]. Leptin-deficient mice presenting 
a mutation in the ‘obese’ gene (i.e., homozygous ob/ob mice) were 
described to develop  severe obesity after the fifth  postnatal week  and 
to exhibit decreased energy expenditure and hyperphagia [2,3]. Leptin 
receptors are predominantly expressed in the hypothalamus, although 
they have also been described to be expressed in extrahypothalamic 
areas like somatosensory thalamic nuclei and the mesolimibic 
dopamine system [4-6]. It has been found that in ob/ob mice dopamine 
is required for hyperphagia [7,8] while manifesting hypoactivation 
of the dopaminergic system [9] that includes disruption in striatal 
dopamine D2 receptors (D2R) [10]. 
Methamphetamine (METH) abuse disrupts dopamine 
neurotransmission and induces neurophysiological and cognitive 
alterations in humans [11,12]. Our group has described multiple 
METH-mediated alterations in mouse cortical and sub-cortical areas 
[13-16],  including changes in mRNA levels of membrane receptors 
and voltage-gated ion channels in medial prefrontal neurons [17]. 
Repeated exposure to cocaine, a psychostimulant that can also increase 
DA neurotransmission, enhanced low threshold T-type calcium 
channel protein levels in mouse somatosensory thalamus neurons [18]. 
Selective targeting of T-type calcium channels using specific blockers 
reduced cocaine-mediated hyperlocomotion concomitantly with a 
reduction in GABAergic neurotransmission onto thalamic ventrobasal 
nucleus [19], thus suggesting the involvement of somatosensory 
ventrobasal thalamic nucleus in locomotor alterations.
We hypothesized that leptin acts as a neuromodulator of 
psychostimulant-mediated changes in locomotor activity and 
thalamocortical excitability mediated by the alteration changes in 
mRNA expression of key voltage-gated calcium channels (P/Q-type and 
T-type), hyperpolarization-activated cyclic nucleotide-gated channels 
(HCN2), and glutamate receptor subunits (AMPA and NMDA) [16-
19]. Behavioural analyses described that both genotypes (wildtype and 
ob/ob) showed METH-induced locomotor sensitization (increased 
locomotion after 7-days compared to day 1) but with lower raw values 
for ob/ob. In addition, METH-treated ob/ob mouse thalamic tissue 
showed altered mRNA expression of voltage-gated calcium channels, 
hyperpolarization-activated cyclic nucleotide-gated channels, and 
glutamate receptor subunits compared to wildtype thalamic neurons. 
Our results suggest that leptin deficiency can alter transcriptional 
regulation in the thalamus and influence basal and METH-elicited 
locomotor behavior.
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Materials and methods
Animals
We used female C57BL/6JFcen wild type (WT) mice (3-6 months 
old, Central Animal Facility at University of Buenos Aires, animal 
protocol #50-2015) or leptin-deficient, homozygous B6.Cg-Lepob/J, 
obese ob/ob mice (kindly provided by Dr. J.J. Poderoso, (INIGEM, 
CONICET-UBA) ). Females were housed four per cage in the absence 
of males, a condition known to maintain them acyclic. Genotyping of 
ob/ob littermates was determined during the second postnatal week 
according to Finocchietto et al. [20].  Principles of animal care were 
in accordance with the ARRIVE guidelines and CONICET (2003), and 
approved by its authorities using OLAW/ARENA directives (NIH, 
Bethesda, MD, USA).
Drug treatments
(+)-Methamphetamine hydrochloride (Sigma, St Louis, MO) was 
administered subcutaneously (sc) once a day for 7 days (1 mg/Kg, 
calculated as free base, dissolved in sterile saline solution). The METH 
regimen used in this study was performed according to studies by González 
et al. [15]. Vehicle groups received the same volume of sterile saline. 
Behavioral studies
Mouse locomotor activity was recorded with an automated system 
(Ethovision XT 7.0, Noldus, The Netherlands) as previously described 
[15,18,19]. Total distance traveled (cm) was quantified for a total of 
5 minutes prior to injections (basal), and 40 minutes following the 
last injection of METH/vehicle for days 1 and 7 (test). Drug-induced 
locomotion was expressed as the ratio between locomotion following 
drug injection and basal locomotion. Locomotor sensitization was 
calculated as the ratio of relative locomotion after the 7-day treatment 
compared to day 1. 
Real time PCR
Mice were killed 4 days after treatments and their brains were rapidly 
removed. The somatosensory thalamic complex (ventrobasal+reticular 
nuclei) was dissected, placed on dry ice, and stored at -70°C in RNAlater 
for further assays. Total RNA was isolated using TRIZOL reagent 
(Invitrogen) according to the manufacturer’s protocol. Five hundred 
nanograms of RNA were treated with DNAseI (Deoxiribonuclease 
I) and reverse-transcribed in a 20 µL reaction using M-MLV reverse 
transcriptase  and random hexameres. For quantitative real-time PCR 
(qPCR) primer sets were designed for the specific amplification of 
murine Cacna1a, Cacna1g, Cacna1i, Hcn2, Gria1, Grin1, and Gapdh as 
a housekeeping control gene [17]. Each sample was assayed in duplicate 
using 4 pmol of each primer, 1X SYBR Green Master Mix,  and 2-20 ng 
of cDNA in a total volume of 13 µL. Amplification was carried out in 
an ABI PRISM 7500 Sequence Detection System. 
Statistical analysis
InfoStat software (www.infostat.com.ar) was used for statistical 
comparisons. Statistics were performed using two-way (genotype and 
treatment) ANOVA followed by  Bonferroni post hoc tests. Differences 
were considered significant if p<0.05.
Pharmacological reagents
Drugs were purchased from either Sigma (St. Louis, MO; USA) or 
Tocris (Ellisville, MO; USA). Reagents for RT-PCR were purchased 
from Qiagen (GermanTown, MD, USA), Applied Biosystems (Foster 
City, CA, USA) or Thermofisher-Invitrogen (Waltham, MA, USA).  
Results
We measured body weight of WT and ob/ob female mice at the 
beginning (day 1) and end (day 7) of treatment. Table 1 shows that at 
both day 1 and day 7 ob/ob mice (OB) were significantly heavier than 
WT littermates. Paired t-test within each group comparing day 1 vs. 
day 7 showed no treatment effect on body weight.
We started assessing basal locomotor activation of either WT and 
ob/ob transgenic mice before METH administration at day 1. Obese ob/
ob female mice showed substantially diminished locomotion througout 
the arena compared to wild type mice (Figure 1B, left). After the first 
METH administration on day 1, both WT and ob/ob mice increased their 
locomotion (Figure 1B, right), while maintaining differences between 
genotypes. At day 7, basal locomotor activity showed interactive effects 
between genotype and treatment, and we found differences betwee 
WT-vehicle and OB, but no changes in locomotion after after METH 
between genotypes (Figure 1C, left). METH-mediated stimulation of 
locomotor activity was significantly higher at day 7 (Figure 1C, right). 
METH-mediated sensitization (i.e., increased METH-induced motor 
activation at day 7 administration compared to day 1) was observed in 
both WT and ob/ob mice (Figure 1D).
We evaluated mRNA expression of voltage-gated calcium 
channels, hyperpolarization-activated cyclic nucleotide-gated (HCN2) 
channels, and glutamate receptor subunits in the somatosensory 
thalamic complex (ventrobasal+reticular nuclei) four days after 
METH treatment (Figure 2). Assays of P/Q-type Cav2.1 (Cacna1a), 
and T-type Cav3.3 (Cacna1i) voltage-gated calcium channel subunits 
showed higher mRNA levels in ob/ob mice relative to WT (Figure 
2A,C). No changes were detected for assays of T-type Cav3.1 mRNA 
levels (Cacna1g) (Figure 2B). The assays of HCN2 showed elevated 
mRNA levels in ob/ob that were down-regulated by METH (Figure 
2D). Assays of NMDA-GluN1 Grin1 (Figure 2E) and AMPA-GluA1 
Gria1 (Figure 2F) mRNA levels were observed to be higher in ob/ob 
mice, independently of METH administration.
Discussion
Results presented here support the hypothesis that the absence of 
leptin regulation during development alters psychostimulant-mediated 
locomotor activity and thalamocortical excitability. In the present 
study we show that repetitive administration of METH induced lower 
locomotor stimulation in leptin-null, ob/ob mice. This effect was also 
observed in the absence of METH. It should be noted that locomotor 
activity tends to be depressed in obese mice, probably due to abnormal 
neuroendocrine function [21]. Locomotor responses to systemic 
administration of 10 mg/kg cocaine was reduced in ob/ob mice, while 
conditioned place preference was increased by 2.5 mg/kg of cocaine 
[22]. These results contributed new important information about 
METH effects on females, extending our group’s previous report [14].
Dopaminergic projections from the ventral tegmental area 
(VTA) to the nucleus accumbens (NAcc), and its control by the 
pedunculopontine nucleus [4], mediate psychostimulant stimulated 
locomotor activity [23]. Dopaminergic modulation is also required 
Body weight (gr)
WT vehicle WT METH OB vehicle OB METH
Day 1 26.7 ± 1.0 25.7 ± 1.1 60.1 ± 3.0 64.8 ± 1.6 
Day 7 26.4 ± 1.0 25.0 ± 1.0 59.2 ± 2.1 63.8 ± 1.4 
Two-way ANOVA-Bonferroni (N=5-6); day 1: F(3,21)=141.94 p<0.0001; genotype effect 
F(1,21)=412.87 p<0.0001 comparing WT vs. OB; day 7: F(3,21)=156.33 p<0.0001; genotype 
effect F(1,21)=454.02 p<0.0001 comparing WT vs. OB).
Table 1. Body weight at the beginning (day 1) and end (day 7) of treatment. 
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Figure 1. A) Schematic figure showing the METH administration protocol used. Methamphetamine (METH) or vehicle were administered once a day for 7 consecutive days. The 
ventrobasal thalami were collected 4 days after the last injection. B) Locomotor response at Day 1. Basal (left panel; two-way ANOVA, F(3,21)=8,34 p<0.001; genotype effect F(1,21)=24.97 
p<0.0001 comparing WT vs. OB) and drug-induced (right panel; two-way ANOVA, F(3,21)=7.93 p<0.01; genotype effect F(1,21)=19.08 p<0.001, WT vs. OB; treatment effect F(1,21)=5.27 
p<0.05, vehicle vs. METH administration) relative locomotion (test/basal) on day 1. C) Locomotor response at Day 7. Basal (left panel; two-way ANOVA, (N=5-6), F(3,21)=16.16 p<0.0001; 
interaction effect F(1,21)=11.95, p<0.01, Bonferroni post-test among all groups) and drug-induced (right panel; two-way ANOVA, (N=5-6), F(3,21)=13.09 p<0.0001; genotype effect F(1,21)=10,86 
p<0.01, WT vs. OB; treatment effect F(1,21)=24.14, p<0.001, vehicle vs. METH administration) relative locomotion (test/basal) on day 7. D) Locomotor sensitization. Relative locomotion 
day 7 – day1. Two-way ANOVA, (N=5-6), F(3,21)=13.09 p<0.0001; treatment effect F(1,21)=14.21, p<0.01, vehicle vs. METH administration). 
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Figure 2. mRNA level expression in ventrobasal thalamic nucleus evaluated by RT-PCR. A-C, mRNA level expression of voltage-gated calcium channels subunits Cacna1a (A; P/Q 
Cav2.1), Cacna1g (B; T Cav3.1), Cacna1i (C; T Cav3.3) (Two-way ANOVA, (N=5), Cacna1a F(3,19)=3.98, p<0.05; genotype effect F(1,19)=6.86, p<0.05 WT vs OB; Cacna1i F(3,19)=3.09, 
p<0.05; genotype effect F(1,19)=8.33, p<0.05 WT vs OB). D, mRNA level expression of HCN subunits Hcn2 (Two-way ANOVA, F(3,19)=5.00, p<0.05; interaction effect F(1,19)=8.22,  p<0.05). 
E, mRNA level expression of glutamate receptors subunits Gria1 and Grin1 (AMPA GluA1 and NMDA GluN1, respectively; two-way ANOVA, Gria1 F(3,19)=6.06, p<0.01; genotype effect 
F(1,19)=16.44, p<0.01 WT vs OB; Grin1 F(3,19)=5.29, p<0.05; genotype effect F(1,19)=15.13, p<0.01 WT vs OB;).
for feeding in ob/ob mice [7-9]. Exogenous leptin administration has 
been shown to reduce repetitive action potential discharge in VTA [24] 
and pedunculopontine neurons [25,26]. Therefore, in leptin-deficient 
ob/ob mice there may be inhibitory mechanisms that compensate for 
leptin-mediated inhibition. D2 receptors are required for locomotor 
sensitization [27]. Reduced striatal D2R binding described  for ob/ob 
mice [10] might explain the lower locomotor activity reported here 
after 7 day METH administration. In conclusion, it may be suggested 
that lack of circulating leptin during development blunted the ob/ob 
response to METH administration.
Voltage-gated T-type calcium channels expressed in the 
somatosensory thalamocortical system have been involved in 
psychostimulant-induced locomotor activation [19,28]. Here, we have 
evaluated mRNA expression of a wide range of voltage-gated calcium 
channels (T and P/Q types), HCN2, and glutamate receptor subunits 
in the somatosensory thalamic complex after METH treatment in both 
WT and ob/ob mice. Higher mRNA expression levels for voltage-gated 
CaV2.1 and CaV3.3 calcium channels and NMDA-GluN1, and AMPA-
GluA1 glutamate receptor subunits were observed in somatosensory 
thalamic neurons in ob/ob mice. METH-administration did not 
influence those changes. No significant changes were observed for 
CaV3.1 calcium channels. Increased mRNA levels were also observed 
for HCN2 channels in ob/ob mice. Interestinlgy, METH administration 
reduced HCN2 levels in the sensory thalamus of ob/ob mice. Further 
experiments are still needed in order to quantify protein levels changes 
of these channels/receptors mediated by METH.
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These transcriptional alterations observed in  thalamic nuclei 
from ob/ob mice might underlie previously described impaired sleep 
consolidation [29]. Indeed, CaV2.1 voltage-gated calcium channels are 
located in the dendrites of ventrobasal neurons and support gamma 
band oscillations that modulate membrane depolarization towards 
action potential threshold [30]. Thalamic reticular neurons express 
CaV3.2 and CaV3.3 T-type calcium channel subunits [31]. CaV3.1 
subunits containing T-type calcium channels are expressed at both 
pre-synaptic thalamic reticular axon terminals and post-synaptic 
ventrobasal cell bodies [32], and are implicated in the transitions 
between waking and slow sleep sleep [33]. Moreover, HCN2 channels 
are involved in controlling thalamocortical activity, reducing the 
susceptibility to convulsant agents [34]. 
In addition, it was reported that somatosensory loss induces 
profound changes in motor adaptation and anticipation in humans 
[35]. Therefore, changes reported here on thalamic nuclei gene 
expression might underlie alterations in somatosensory processing 
that might in turn induce detrimental effects on locomotion. Further 
studies are needed on psychostimulant-mediated actions in this and 
other leptin resistance animal models to elucidate their effects on 
sensory and motivational brain networks.
Funtional implications for thalamocortical rhytmicity
Voltage-gated ionic channels are responsible for neuronal 
excitability, endowing them with autorhythmic membrane oscillatory 
capabilities [36]. Synaptic receptors mediate functional contacts 
between neurons, spreading oscillations throughout neuronal 
networks. In such networks, autorhythmic neurons may either act as 
oscillators/pacemakers or as resonators [36,37]. Changes described 
here for mRNA levels of voltage-gated ionic channels and synaptic 
receptors would affect neuronal oscillations in the CNS. Indeed, 
blocking or transgenic elimination of P/Q-type calcium channels have 
been described to prevent the generation of gamma band oscillations 
[30,37,38]. T-type and HCN channels are physically associated [39] to 
underlie low-frequency oscillatory activity at the thalamocortical level 
[33,38,39,40]. Indeed, T-type channels are key elements mediating the 
sensitivity to psychostimulants [19,28], consistent with the observed 
enhancement in low frequency oscillatory activity after METH [41,42] 
and changes in protein levels of T-type channels mediated by cocaine 
[43] administration. Further studies are needed to clarify METH-
dependent alterations of voltage-gated ionic channels and glutamate 
receptors protein levels. 
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